MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)
Parabilis Medicines (PBLS), formerly, Fog Pharmaceuticals, Inc. (FogPharma)
Organization & Developments: FogPharma
Parents
Parabilis Medicines (PBLS), formerly, Fog Pharmaceuticals, Inc. (FogPharma)
Children
*“Helicons” — helix-shaped peptide drugs that can get into cells and battle tough-to-reach, cancer-driving proteins.
*Parabilis was founded by serial biotech entrepreneur Gregory Verdine, whose early research helped lay the groundwork for a breakthrough pancreatic cancer drug now being developed by Revolution Medicines.
*Verdine has long been focused on “undruggable” proteins, and formed Parabilis — once known as FogPharma — to pursue a different way of accessing them.
2024: FogPharma bags $145M, adds Alexis Borisy to the board
2026: Parabilis sets a record with a $670M biotech IPO
Jumps
Finance & Acquisitions: FogPharma
Key People: FogPharma